(Q39228559)

10 September 2017

title

AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells (English)

1 reference

10 September 2017

1 reference

lymphoblastic leukemia

1 reference

5

1 reference

10 September 2017

12

1 reference

10 September 2017

M Curtarello

4

0 references

author name string

B Accordi

1

1 reference

10 September 2017

L Galla

2

1 reference

10 September 2017

G Milani

3

1 reference

10 September 2017

V Lissandron

6

1 reference

10 September 2017

G Viola

7

1 reference

10 September 2017

G te Kronnie

8

1 reference

10 September 2017

R De Maria

9

1 reference

10 September 2017

E F Petricoin

10

1 reference

10 September 2017

L A Liotta

11

1 reference

10 September 2017

G Basso

13

1 reference

10 September 2017

publication date

21 November 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

27

1 reference

10 September 2017

issue

5

1 reference

10 September 2017

page(s)

1019-1027

1 reference

The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

AMP-activated protein kinase--development of the energy sensor concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Structural basis for AMP binding to mammalian AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

LKB1-dependent signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

The AMP-activated protein kinase--fuel gauge of the mammalian cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

The AMP-activated protein kinase pathway--new players upstream and downstream.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

AMP-activated protein kinase and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Inhibition of adenosine monophosphate-activated protein kinase induces apoptosis in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

AMP-activated protein kinase promotes human prostate cancer cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

AMP-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

A human acute lymphoblastic leukemia line with the T(4;11) translocation as a model of minimal residual disease in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Central role of mitochondria and p53 in PUVA-induced apoptosis in human keratinocytes cell line NCTC-2544.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Interferon-alpha gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Hepatocyte growth factor receptor c-MET is associated with FAS and when activated enhances drug-induced apoptosis in pediatric B acute lymphoblastic leukemia with TEL-AML1 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Activation of AMP-activated Protein Kinase by Temozolomide Contributes to Apoptosis in Glioblastoma Cells via p53 Activation and mTORC1 Inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

AMPK as a therapeutic target in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

5'AMP-activated protein kinase alpha deficiency enhances stress-induced apoptosis in BHK and PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Up-regulation of AMP-activated protein kinase in cancer cell lines is mediated through c-Src activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Liver kinase B1 (LKB1) in the pathogenesis of UVB-induced murine basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

Energy-dependent regulation of cell structure by AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

The Drosophila Lkb1 kinase is required for spindle formation and asymmetric neuroblast division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.338

21 January 2018

Identifiers

DOI

10.1038/LEU.2012.338

1 reference

Dimensions Publication ID

10 September 2017

1000536719

0 references

1 reference